SNPS vs TCRX · P/E 63, rev $7.16B vs rev $2.0M
Synopsys Inc (SNPS) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US. It is led by Sassine Ghazi.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
SNPS currently screens at market cap $85.14B and trailing P/E 63.3. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the SNPS and TCRX stock pages for the full models.
Not investment advice.